All In Biotech

Free tool

FAERS Monitor: Monistat 3 Combination Pack

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021261 or its brand name (Monistat 3 Combination Pack, Miconazole Nitrate). Reports on generic versions are filed under their own applications.

Reports

2,640

Serious

800

30% of reports

Hospitalization

329

Death reported

86

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • vulvovaginal burning sensation742
  • vulvovaginal pain525
  • drug ineffective313
  • vulvovaginal pruritus253
  • vaginal haemorrhage235
  • vulvovaginal discomfort192
  • condition aggravated179
  • vulvovaginal swelling155
  • pain102
  • pruritus74
  • abdominal pain71
  • hypersensitivity69
  • burning sensation66
  • off label use66
  • drug interaction62

Reports by year received

View as table
YearReports
200414
200520
200620
200713
200836
200966
201042
201146
201273
201316
201423
201531
2016122
2017112
2018202
2019196
2020207
2021264
2022243
2023162
2024222
2025266
2026244

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,519 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
vulvovaginal burning sensationSignal7421102.21031.2716,469
vulvovaginal painSignal525974.3897.4454,098
vulvovaginal swellingSignal155738.8629.5103,853
vulvovaginal pruritusSignal253418.8371.399,820
vulvovaginal discomfortSignal192361.8314.765,748
vaginal haemorrhageSignal23543.438.49,651
burning sensationSignal667.55.9367
condition aggravatedSignal1794.74.1524
drug interactionSignal623.12.488
hypersensitivitySignal693.02.388
abdominal painSignal712.41.959
drug ineffective3131.91.7140
pruritus741.51.213
pain1021.31.18
off label use660.60.518

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.